Want to see EXPO full AI Analyst Report?
EXPO Stock Chart & Stats
$61.44
$1.32(2.15%)
At close: 4:00 PM EDT
$61.44
$1.32(2.15%)
Day’s Range― - ―
52-Week Range$51.91 - $81.95
Previous Close$62.76
Volume529.68K
Average Volume (3M)575.32K
Market Cap
$3.24B
Enterprise Value$3.00K
Total Cash (Recent Filing)$66.63M
Total Debt (Recent Filing)$80.72M
Price to Earnings (P/E)30.1
Beta0.79
Next Earnings
Oct 22, 2026EPS Estimate
0.6Next Dividend Ex-DateN/A
Dividend Yield1.82%
Share Statistics
EPS (TTM)2.23
Shares Outstanding47,546,085
10 Day Avg. Volume536,401
30 Day Avg. Volume575,324
Financial Highlights & Ratios
PEG Ratio-14.37
Price to Book (P/B)9.15
Price to Sales (P/S)6.14
P/FCF Ratio29.19
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$84.00Price Target Upside36.72% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)2.31
Revenue Forecast (FY)$587.40M
Bulls Say, Bears Say
Bulls Say
High And Expanding Operating MarginsSustained high EBITDA margins and a raised margin guidance indicate structural pricing power in technical consulting. High margins support durable cash generation, fund talent/research investments, and provide insulation versus cyclical revenue dips, enhancing long‑term profit resilience.
Strong Free Cash Flow Generation And ConversionRobust FCF and near‑one‑for‑one conversion from net income underpin sustainable capital allocation: dividends, buybacks, and selective investments. Low capex needs enhance cash flexibility, enabling long‑term shareholder returns and funding strategic hires without heavy external financing.
Durable Demand From Multidisciplinary And AI-driven WorkStructural tailwinds—AI product testing, regulatory complexity, and infrastructure risk—map to Exponent’s multidisciplinary expertise. This creates lasting demand for specialized consulting, diversifies end markets, and forms a knowledge‑based moat that supports steady revenue over multiple cycles.
Bears Say
Reimbursable Expense Volatility And ConcentrationHeavy reliance on reimbursable user research projects can produce quarter‑to‑quarter swings and client concentration. That variability reduces revenue predictability and complicates capacity planning and utilization targets, increasing execution risk over the medium term.
Rising G&A And Operating CostsGrowing overhead and people‑related costs can erode operating leverage if revenue growth slows. Persistent increases in recruiting, development, and travel may compress margins over time, requiring sustained rate or utilization improvements to preserve profitability.
Higher Leverage And Reduced Cash Cushions After BuybacksIncreased leverage and significant share repurchases have lowered cash reserves and reduced balance‑sheet flexibility. That limits the firm’s buffer for hiring, M&A, or cyclical downturns and raises risk if demand or utilization unexpectedly weakens.
Exponent News
EXPO FAQ
What was Exponent’s price range in the past 12 months?
Exponent lowest stock price was $51.91 and its highest was $81.95 in the past 12 months.
What is Exponent’s market cap?
Exponent’s market cap is $3.24B.
When is Exponent’s upcoming earnings report date?
Exponent’s upcoming earnings report date is Oct 22, 2026 which is in 68 days.
How were Exponent’s earnings last quarter?
Exponent released its earnings results on Jul 30, 2026. The company reported $0.6 earnings per share for the quarter, beating the consensus estimate of $0.549 by $0.051.
Is Exponent overvalued?
According to Wall Street analysts Exponent’s price is currently Undervalued.
Does Exponent pay dividends?
Exponent pays a Quarterly dividend of $0.31 which represents an annual dividend yield of 1.82%. See more information on Exponent dividends here
What is Exponent’s EPS estimate?
Exponent’s EPS estimate is 0.6.
How many shares outstanding does Exponent have?
Exponent has 47,546,085 shares outstanding.
What happened to Exponent’s price movement after its last earnings report?
Exponent reported an EPS of $0.6 in its last earnings report, beating expectations of $0.549. Following the earnings report the stock price went up 3.531%.
Which hedge fund is a major shareholder of Exponent?
Currently, no hedge funds are holding shares in EXPO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Exponent Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$84.00 (36.72% Upside)
$84.00 (36.72% Upside)
Blogger Sentiment
Bullish
EXPO Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 511.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $491.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 13.4%
Last 30 Days ▲ 13.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.30%
12-Months-Change
Fundamentals
Return on Equity
1.82%
Trailing 12-Months
Asset Growth
-14.05%
Trailing 12-Months
Company Description
Exponent
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics, and vehicle system engineering. Concurrently, the Environmental and Health segment specializes in areas such as chemical regulatory compliance, food safety, ecological and biological studies, earth and environmental sciences, and various health-related scientific fields. With expertise spanning approximately 90 technical disciplines, Exponent is dedicated to addressing complex and pressing issues for its stakeholders. Its client base is diverse, covering industries like chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, heavy industrial equipment, and transportation. The company, originally established in 1967 as The Failure Group, Inc., rebranded as Exponent, Inc. in 1998, and its headquarters are located in Menlo Park, California.
EXPO Company Deck
EXPO Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a positive operational and financial performance: double-digit revenue and earnings growth, higher utilization, EBITDA margin expansion, strong AI-driven demand across proactive and reactive services, and an upward revision to full-year guidance. Offsetting factors include quarter-to-quarter variability from reimbursable user research projects (including one large study that temporarily boosted results), rising G&A and operating expenses, reduced interest income and cash due to substantial share repurchases, and modest increases in realized billing rates and tax rate. On balance, the strengths and forward guidance outweigh the highlighted risks and one-time variabilities.View all EXPO earnings summariesEXPO Stock 12 Month Forecast
Average Price Target
$84.00
▲(36.72% Upside)
Technical Analysis
Booz Allen
―
Cra International
―
FTI Consulting
―
Huron Consulting
―
Icf International
―
Ownership Overview
1.22% Insiders
30.88% Mutual Funds
23.46% Other Institutional Investors
9.47% Public Companies and
Individual Investors